Skip to main content

Advertisement

Table 1 Subject characteristics

From: Therapeutic effect of Yang-Xue-Qing-Nao granules on sleep dysfunction in Parkinson’s disease

Subjects Control group (n = 35) Placebo group (n = 30) YXQN group (n = 31) P value
Age (yr) 66.8 ± 7.7 67.1 ± 10.2 68.6 ± 9.2 0.89
Men/Women 21/14 19/11 18/13 -
Disease duration - 6.1 ± 4.9 5.9 ± 4.7 0.17
UPDRS score - 37.59 ± 10.51 38.35 ± 6.78 0.23
Levodopa/DCI (mg/day) - 412.5 ± 162.8 421.3 ± 142.9 0.65
Pramipexole(mg/day) - 1.11 ± 0.39 1.03 ± 0.78 0.08
Entacapone (mg/day) - 198.28 ± 88.47 203.67 ± 78.38 0.12
Selegiline hydrochloride (mg/day) - 8.33 ± 6.94 8.21 ± 3.76 0.26
Adamantatamine (mg/day) - 118.73 ± 96.59 116.31 ± 89.6 0.19
Artane hydrochloride (mg/day) - 4.82 ± 2.91 4.65 ± 2.36 0.08